Granules India Limited (BOM:532482)
India · Delayed Price · Currency is INR 842.55
+8.90 (1.07%)
At close: Jul 27, 2026
Granules India Market Cap
Granules India has a market cap or net worth of 208.78 billion as of July 27, 2026. Its market cap has increased by 83.58% in one year.
Market Cap
208.78B
Enterprise Value
214.56B
Revenue
56.32B
Ranking
n/a
PE Ratio
31.26
Stock Price
842.55
ChartMarket Cap Chart
Since February 7, 2003, Granules India's market cap has increased from 163.70M to 208.78B, an increase of 127,438.90%. That is a compound annual growth rate of 35.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 208.78B | 43.74% |
| Dec 31, 2025 | 145.25B | 1.29% |
| Dec 31, 2024 | 143.40B | 45.94% |
| Dec 29, 2023 | 98.26B | 27.40% |
| Dec 30, 2022 | 77.13B | -7.49% |
| Dec 31, 2021 | 83.37B | -4.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 595.05B |
| GlaxoSmithKline Pharmaceuticals | 425.76B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 250.45B |
| AstraZeneca Pharma India | 204.20B |
| Caplin Point Laboratories | 187.34B |
| Jubilant Pharmova | 152.38B |
| CORONA Remedies | 129.23B |